1. Home
  2. GLPG vs LB Comparison

GLPG vs LB Comparison

Compare GLPG & LB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • LB
  • Stock Information
  • Founded
  • GLPG 1999
  • LB 1992
  • Country
  • GLPG Belgium
  • LB United States
  • Employees
  • GLPG N/A
  • LB N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • LB
  • Sector
  • GLPG Health Care
  • LB
  • Exchange
  • GLPG Nasdaq
  • LB NYSE
  • Market Cap
  • GLPG 1.8B
  • LB 1.5B
  • IPO Year
  • GLPG 2005
  • LB 2024
  • Fundamental
  • Price
  • GLPG $24.77
  • LB $72.71
  • Analyst Decision
  • GLPG Sell
  • LB Buy
  • Analyst Count
  • GLPG 5
  • LB 8
  • Target Price
  • GLPG $26.75
  • LB $56.75
  • AVG Volume (30 Days)
  • GLPG 159.3K
  • LB 661.9K
  • Earning Date
  • GLPG 04-23-2025
  • LB 03-05-2025
  • Dividend Yield
  • GLPG N/A
  • LB 0.28%
  • EPS Growth
  • GLPG N/A
  • LB N/A
  • EPS
  • GLPG 1.16
  • LB 0.07
  • Revenue
  • GLPG $285,380,474.00
  • LB $109,954,000.00
  • Revenue This Year
  • GLPG $0.08
  • LB $69.52
  • Revenue Next Year
  • GLPG $0.23
  • LB $14.68
  • P/E Ratio
  • GLPG $21.58
  • LB $1,007.35
  • Revenue Growth
  • GLPG 14.99
  • LB 50.90
  • 52 Week Low
  • GLPG $22.36
  • LB $18.75
  • 52 Week High
  • GLPG $32.17
  • LB $84.70
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 38.92
  • LB N/A
  • Support Level
  • GLPG $24.48
  • LB N/A
  • Resistance Level
  • GLPG $25.72
  • LB N/A
  • Average True Range (ATR)
  • GLPG 0.51
  • LB 0.00
  • MACD
  • GLPG -0.15
  • LB 0.00
  • Stochastic Oscillator
  • GLPG 14.15
  • LB 0.00

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About LB LANDBRIDGE COMPANY LLC

LandBridge Co LLC is engaged in managing land and resources to support and promote oil and natural gas development. It generate revenue streams from the use of its surface acreage, the sale of resources from land and oil and gas royalties.

Share on Social Networks: